Viatris Inc. (VTRS): Price and Financial Metrics

Viatris Inc. (VTRS): $10.47

0.21 (+2.05%)

POWR Rating

Component Grades








Add VTRS to Watchlist
Sign Up

VTRS Price/Volume Stats

Current price $10.47 52-week high $13.62
Prev. close $10.26 52-week low $8.74
Day low $10.17 Volume 29,958,500
Day high $10.50 Avg. volume 9,204,608
50-day MA $10.98 Dividend yield 4.78%
200-day MA $10.79 Market Cap 12.47B

VTRS Stock Price Chart Interactive Chart >

Viatris Inc. (VTRS) Company Bio

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania. The company was formed through the merger of Mylan and Upjohn, a division of Pfizer, on November 16, 2020. (Source:Wikipedia)

VTRS Latest News Stream

Event/Time News Detail
Loading, please wait...

VTRS Latest Social Stream

Loading social stream, please wait...

View Full VTRS Social Stream

Latest VTRS News From Around the Web

Below are the latest news stories about VIATRIS INC that investors may wish to consider to help them evaluate VTRS as an investment opportunity.

Regeneron Gains After Eye-Drug Patent Victory Over Viatris

(Bloomberg) -- Regeneron Pharmaceuticals Inc. rose the most in almost two months after a court ruled that the drugmaker’s patent rights were infringed by a cheaper copy of its eye drug developed by Viatris Inc. Most Read from BloombergThe Late-Night Email to Tim Cook That Set the Apple Watch Saga in MotionChinese Carmaker Overtakes Tesla as World’s Most Popular EV MakerBridgewater CEO’s Past Office Romance Led to Favoritism ClaimsXiaomi Unveils Its First EV, With Ambition to Be China’s Porsche o

Yahoo | December 27, 2023

Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024. Chief Executive Officer Scott A. Smith, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will represent the company in a presentation followed by a fireside chat scheduled at 10:30 a.m. PST / 1:30 p.m. ET.

Yahoo | December 21, 2023

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Yahoo | December 19, 2023

UPDATE 1-Drugmaker Viatris appoints Theodora Mistras as CFO

Global healthcare company Viatris on Friday appointed Theodora Mistras as its chief financial officer, effective March 1. The company said the current CFO Sanjeev Narula will work closely with Mistras to support a smooth transition and will then depart the company on March 1. Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said.

Yahoo | December 15, 2023

Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that, as it prepares to enter Phase 2 of its strategic plan, Theodora "Doretta" Mistras has been appointed Chief Financial Officer (CFO) effective March 1, 2024, and Philippe Martin has been appointed Chief R&D Officer with immediate effect.

Yahoo | December 15, 2023

Read More 'VTRS' Stories Here

VTRS Price Returns

1-mo -2.65%
3-mo -10.58%
6-mo 0.38%
1-year 8.93%
3-year -16.52%
5-year -34.74%
YTD -1.29%
2023 2.06%
2022 -14.29%
2021 -26.12%
2020 -6.77%
2019 -26.64%

VTRS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full VTRS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!